Skip to main content
. 2008 Oct 17;113(2):299–305. doi: 10.1182/blood-2008-02-137943

Table 1.

Patient characteristics

Characteristic No.
Sex
    Men 20
    Women 6
Age, y
    Median 60
    Range 46-76
ECOG performance status
    0 7
    1 18
    ND 1
Rai stage
    I-II 7
    III-IV 19
Prior regimens
    Median 4
    Range 2-12
    Fludarabine 26
    Refractory to fludarabine 22
    Alkylating agents 25
    Rituximab 24
    Alemtuzumab 11

ECOG indicates Eastern Cooperative Oncology Group; and ND, not documented.